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INTRODUCTION
Propafenone (2’-[3’(propylamino)-2-(hydroxy)propoxy]-3-
Phenylptopiophenone hydrochloride) is a widely used antiar-
rhythamic drug. Electrophysiological studies in animal mod-
els have shown that propafenone reduces the maximum rate
of rise and the amplitude of the action potential (1), and
increases the duration of the action potential (2, 3). Further-
more, the drug has been shown to depress the transient out-
ward current (Ito) in atrial myocytes of the rabbit and ven-
tricular myocytes of the rat (4), the hyperpolarization-acti-
vated inward current (If) in isolated human atrial myocytes
(5) and the delayed rectifier current (Ikr) in sinoatrial node
cells and atrial myocytes of rabbits and ventricular myocytes
of guinea pigs (3, 4, 6).
Voltage-operated potassium currents play important roles
in shaping and terminating cardic action potentials. Although
several potassium current components have been isolated,
two types of currents can be distinguished: fast activating
and inactivating currents, referred to as Ito, and delayed,
more slowly inactivating currents, referred to as Ikr (7). For
Ito, in particular, kv1.4 potasium channel has been identi-
fied or discussed, since the kv1.4 channel carries the Ito cur-
rent which is a major contributor to the repolarizing currents
terminating the cardic action potential. Several experiments
have showed that the expression of kv1.4 channels in heart
is altered under pathologic conditions associated with arrhyth-
mias. Thus, 1) hyperthyroidism drastically decreased the
protein level of kv1.4 in cultured newborn rat ventricular
myocytes (8); 2) rats with infarcted myocardium showed
reduced mRNA and protein levels of kv1.4 in different regions
of left ventricular myocardium (9); 3) cardic hypertrophy in
rats (induced by phorbol esters) increased the density of kv1.4
(10); 4) diabetic heart (induced by streptozotocin) yielded a
increase of kv1.4 mRNA density and protein level in rat ven-
tricle (11). 
Therefore, understanding the molecular basis of the kinetic
behavior of kv1.4 channels in response to changes in PH and
[K]0 may be of considerable physiological important. We
used an N-terminal deletion construct of kv1.4 (kv1.4 N),
which lacks rapid N-type inactivatin, but exhibits robust C-
type inactivation (12, 13). In the present study, we aimed to
investigate effects and mechanism of action of propafenone
on the kv1.4 N channel, and to examine the response to
changes in PH and [K
+]0.
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Regulation of Antiarrhythmic Drug Propafenone Effects on the C-type
KV1.4 Potassium Channel by PHo and K
+
The effects of the antiarrhythmic drug propafenone at c-type kv1.4 channels in Xeno-
pus laevis oocytes were studied with the two-electrode voltage-clamp techinique.
Defolliculated oocytes (stage V-VI) were injected with transcribed cRNAs of ferret
Kv1.4 N channels. During recording, oocytes were continuously perfused with
control solution or propafenone. Propafenone decreased the currents during volt-
age steps. The block was voltage-, use-, and concentration- dependent manners.
The block was increased with positive going potentials. The voltage dependence
of block could be fitted with the sum of monoexponential and a linear function.
Propafenone accelerated the inactivate of current during the voltage step. The con-
centration of half-maximal block (IC50) was 121 μ M/L. With high, normal, and low
extracellular potassium concentrations, the changes of IC50 value had no signifi-
cant statistical differences. The block of propafenone was PH- dependent in high-,
normal- and low- extracellular potassium concentrations. Acidification of the extra-
cellular solution to PH 6.0 increased the IC50 values to 463 μ M/L, alkalization to PH
8.0 reduced it to 58 μ M/L. The results suggest that propafenone blocks the
kv1.4 N channel in the open state and give some hints for an intracellular site of
action. 
Key Words : Potassium Channels; Anti-arrhythmic drug; Ion Channels, Voltage-Gated; Voltage Clamp; Mem-
brane Currents
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Molecular biology 
The constructs and sequences of the cDNAs ferret Kv1.4 N
(fKv1.4 N) used in this study have been previously described
(12, 13). Ferret Kv1.4 N channels possess slow (C-type)
inactivation (12, 13). Removal of residues 2-146 from the
N-terminal domain (fKv1.4 N) results in the loss of the
fast component of inactivation but leaves C-type inactivation. 
Oocytes were collected from mature female Xenopus lae-
vis under anaesthesia (immersion in 1.5 g l
-1 tricaine). The
follicular layer was removed enzymatically by placing the
lobes in a collagenase-containing, Ca
2+-free OR2 solution
(mM: 82.5 NaCl, 2 KCl, 1 MgCl2 and 5 Hepes, pH 7.4,
with 1-2 mg mL
-1 collagenase (Type I, Sigma). The oocytes
were gently shaken for about 2 hr and collagenase activity
was then halted by bovine albumin as previously described
(12). Defolliculated oocytes (stage V-VI) were then injected
with transcribed cRNAs (up to 27-34 nL) and incubated at
18℃ for 24-72 hr in antibiotic-containing Barth’s solution
(mM: 88 NaCl, 1 KCl, 2.4 NaHCO3, 0.82 MgSO4, 1.5 CaCl2
and 5 Hepes, pH 7.4) which was supplementd with penicillin
(100 IU/mL). 
Electrophysiology 
Oocytes were clamped using a two-microelectrode bath
clamp amplifier (CA-1B, Dagan Corp, Minneapolis, MN,
U.S.A.). Microelectrodes were made from borosilicate glass
tubing and had a resistance of 0.5-1 M for the current elec-
trodes and 1-2 M for the potential electrodes when filled
with 3 M/L KCl. During recording, oocytes were continu-
ously perfused with control solution (mM: 96 NaCl, 2 KCl,
1 MgCl2, 1.8 CaCl2 and 10 Hepes, adjusted to pH 7.4 with
NaOH) or high extracellular potassium concentration solu-
tion (mM: 98 KCl, 1 MgCl2, 1.8 CaCl2 and 10 Hepes, adjust-
ed to pH 7.4 with NaOH) or normal extracellular potassi-
um concentration solution (mM: 93 NaCl, 5 KCl, 1 MgCl2,
1.8 CaCl2 and 10 Hepes, adjusted to pH 7.4 with NaOH)
or low extracellular potassium concentration solution (mM:
97 NaCl, 1 KCl, 1 MgCl2, 1.8 CaCl2 and 10 Hepes, adjust-
ed to pH 7.4 with NaOH) The PH value of this solution
was changed in some experiments and was set 6.0 with HCL
and to 8.0 with NaOH. Whenever propafenone was used,
10 min of perfusion time was used to allow equilibration of
propafenone with the oocyte. Propafenone (as hydrochloride;
Sigama, isenhofen, Bayern, Germany) in final concentrations
of 0.01 μ M/L up to 1,000 μ M/L was added to the bath solu-
tion. Solutions were applied with a concentration-clamp
techinique for oocytes (14). All experimnts were performed
at days 1 and 3 after injection of cRNA and were carried out
at room temperature (22±1℃). Currents were filtered at
0.5 kHz. 
Data analysis 
Data were recorded on videotape using an A/D VCR adaptor
(Axon Instruments, Union City, CA, U.S.A.) and were digi-
tised and analysed directly using pCLAMP 9 software (Axon
Instruments, Union City, CA, U.S.A.), Microsoft Excel (Micro-
soft, Redmond, WA, U.S.A.). Unless otherwise stated, raw
data traces from two-microelectrode voltage-clamp record-
ings were not leakage or capacitance subtracted.
The potassium current amplitude was measured at the
peak of current obtained during the depolarizing voltage
step. Conductance-voltage relations were obtained by nor-
malizing the conductance data to the maximal value under
control conditions and by fitting the data to the Boltzmann
equation y=Gmax (1+exp [(V1/2-V)/b]), where y is the normal-
ized conductance, Gmax is the normalized maximal conduc-
tance, V1/2 is the potential of the half-maximal conductance,
V is the voltage, and b is the slope factor. Concentration-
response curves were determined by fitting the mean cur-
rent values at different PROP concentrations to the Lang-
muir equation y=(KD/c)
nH/[1+(KD/c)
nH], where y is the frac-
tion of control current, KD is the half blocking concentra-
tion, c is the concentration of PROP, and 
nH is the Hill coef-
ficient. The voltage dependence of block was determined
using the KD values that were obtained for these calculations
from the fractional current (f), measured as the current in
the presence of propafenone (PROP) at a concentration [D]
of 100 μ M and under control conditions (ICTRL) at the end of
the voltage step: f=IPROP/ICTRL and KD=[D]×f/(1-f). Data are
shown as means±S.E.M. Confidence levels were calculated
using Student’s paired t-test. 
RESULTS
With application of depolarizing voltage steps to oocytes
injected with fkv1.4 N cRNA, outward currents appeared
at potentials of around -40 mv (Fig. 1A). The currents dur-
ing the voltage step increased slowly. The currents reached
the maximum at around +50 mv (Fig. 1B). The administra-
tion of 100 μ M/L propafenone resulted in a decreased of the
sustained currents (Fig. 1B, open squares).
The block of the sustained currents showed a voltage depen-
dence with the largest blocking effect at the highest ampli-
tudes (Fig. 2). The kinetics of the fkv1.4 N currents were
affected by propafenone depending on voltage. The currents
were reduced by propafenone over the whole potential range
(Fig. 2, n=10). At a potential +50 mv, 100 μ M/L propafenone
reduced the amplitude of the current to 41% of the control
value. The block appeared to be voltage-dependent and to
be increased in the positive potential range (from 61±4%
fraction of control current amplitude at -40 mv to 32±2%
at +50 mv with 100 μ M/L propafenone). Voltage depen-
dence of propafenone-induced block of fkv1.4 N currents
Regulation Effects on C-type KV1.4 by PHo and K
+ 85was presented after application of 10 μ M/L, 100 μ M/L, and
1,000 μ M/L propafenone, respectively. At a potential +50
mv, 1,000 μ M/L propafenone (Fig. 2, triangles) reduced the
amplitude of the current more than that of 100 μ M/L (Fig.
2, squares) and 10 μ M/L (Fig. 2, diamonds). 
Frequent-dependent block of fKv1.4 N channels induced
by propafenone can be identified in Fig. 3. The current induced
by the first pulse of the pulse train in the presence of 100 μ M
propafenone was dramatically decreased comparing with that
in the pre-drug control (p<0.05, n=5) and then quickly reach-
es a steady-state current level, when the cell was continuously
stimulated at 1 Hz. All these behaviors reflected the process
of 100 μ M propafenone blocking fKv1.4 N (at +50 mV) and
showed a use-dependent kinectics. It showed with the increas-
ing of numbers of opening channels, the block of propafenone
on fKv1.4 N increased, that is open channel block.
Fig. 4 showed the effect of propafenone on fKv1.4 N
recovery from inactivation with a standard two-pulse proto-
col. The fKv1.4N channel in propafenone recovered more
slowly than the channel in control (Fig. 4A) (p<0.05, n=5).
With the increasing of inter-pulse duration, the normalized
current increased without decreasing at the end of the curve.
It can be concluded that closed state inactivation does not
exist and just open channel block exists. The 50% recovery
time was 980±89.39 ms for controland it was 1,653.15±
108.45 ms for drug-treated group (Fig. 4B) (p<0.05, n=5).
This change in time constant with propafenone suggests
that prpafenone can accelerate the inactivation of fkv1.4 N
currents (Fig. 5, n=8). At a potential of +50 mv the time con-
stants of monoexponential fits were found to 4,494±508 ms
under control conditions and 704±179 ms with 100 μ M/L
86 Z. Wang, S. Wang, J. Li, et al.
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Fig. 1. Current-voltage relationship of fkv1.4 N currents under control condition (CTRL; filled symbols) and propafenone (open symbols;
100 μ M/L PROP). Xenopus oocytes with all covering tissues. (A) original recordings, (B) current-voltage relationships of currents at the end
of the voltage step. The symbols represent means±SEM of 14 experiments. Voltage steps were elicited from the holding potential of -80 mv
to potential up to +50 mv. The currents were normalized to the respective maximal current amplitude under control condition (I current, U
voltage).
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Fig. 2. Voltage dependence of propafenone-induced block of
fkv1.4 N currents. The concentration of propafenone were chang-
ed by 10 μ M (diamonds) and 100 μ M (squares) and 1,000 μ M
(triangles). Xenopus oocytes with all covering tissues. The graphi-
cal evaluation shows the fraction of inhibition of the fkv1.4 N cur-
rents in the potential range from -40 mv to +50 mv from 9 experi-
ments.
Fig. 3. Frequency-dependent block of fKv1.4 N channel induced
by propafenone. The currents were induced by a series of 500
ms depolarizing pulses from -80 to +50 mV with a frequency of 1
Hz for a period of 1 min in control solution (circles) and 100 μ M
propafenone (squares). The peak currents were normalized to
the maximum peak current under control condition and plotted
against pulse number.
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propafenone. There was significant difference between the
time of constants for fkv1.4 N under control conditions
and propafenone with 100 μ M/L. 
The concentration dependence of the propafenone effect
was obtained by eliciting fkv1.4 N currents at propafenone
concentrations between 1 μ M/L and 1,000 μ M/L and by fit-
ting the amplitudes of the currents with Langmuir equa-
tions (Fig. 6A, n=5). The maximal block of the fkv1.4 N
currents was 93% and was almost completely blockade by
1,000 μ M/L. The concentration of half-maximal block (IC50)
was 121 nM/L for the fkv1.4 N by propafenone.
The concentration dependence of the propafenone effect
was also studied in high-potassium solution (98 mM), nor-
mal-potassium solution (5 mM) and low-potassium solution
(1 mM) in Fig. 6B (n=5). Under control conditions of differ-
ent extracellular potassium concentration, the fractioins of
inhibition of propafenone at a concentration of 1,000 μ M/L
were 83%, 89%, and 94%, respectively. The Ic50 for propa-
fenone block of the fkv1.4 N currents in 98[K
+]0, 5 mM[K
+]0,
and 1 mM[K
+]0 were 153 μ M/L, 128 μ M/L, and 94 μ M/L,
respectively. The Ic50 values were changed slightly and have
no significant statistically differences.
Effects of extracellular PH on the concentration dependence
of the propafenone effect were studied on fkv1.4 N currents
in extracellular potassium concentration of 98 mM[K
+]0, 5
mM[K
+]0, and 1 mM[K
+]0 (Fig. 7, n=5). With extracellular
potassium acide solution (PH 6, triangles), neutral solution
(PH 7.4, squares) and alkaline solution (PH 8, diamonds),
propafenone was applied in concentration between 10 μ M/L
and 1,000 μ M/L and the currents were fitted with Lang-
muir equations. 
As described in literature, the kinetics of the fkv1.4 N
currents were PH-dependent and the deactivation was acceler-
ated with acidification and slowed down with alkalization in
high-, normal- and low- extracellur potassium concentration.
The sensitivity of the fkv1.4 N to propafenone, however,
Control
100 μ M propafenone
Fig. 4. Effect of propafenone on fKv1.4 N recovery from C-type inactivation. The membrane was depolarized to +50 mV from the hold-
ing potential -80 mV for 5s (P1) followed by a second pulse (P2) to +50 mV for 1s with variable inter-pulse durations (inter-pulse potential
was -80 mV). The inter-pulse durations were set as the following: 0.1 sec, 0.2 sec, 0.3 sec, 0.4 sec, 0.5 sec, 1 sec, 2 sec, 3 sec, 4 sec, 5
sec, 10 sec, and 20 sec. The peak currents induced by P2 were normalized to peak current induced by P1 and plotted against inter-pulse
duration (A). (B) showed recovery time constants for control and 100 μ M propafenone treated groups (n=5, p<0.05 ). 
Fig. 5. graphical evaluation of the time constant ( τ ) of monoexponential fits. Xenopus oocytes with all covering tissues. Original record-
ings (A) and graphical evaluation of the time constant of monoexponential fits (B). The original recordings under control conditions and
graphical evaluation of the time constant of monoexponential fits (A). The original recordings under control conditions and propafenone
were obtained at voltage steps to +50 mv.
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was altered with PH. Whereas the IC50 value increased in
acidic solution to 463 μ M/L, it was decreased in the alkaline
extracellular solution to 58 μ M/L (differences statistically sig-
nificant) for the high extracellular potassium concentration.
DISCUSSION
Kv1.4 channel mediate a slowly recovering outward cur-
rent with upregulated expression during ischemia. There-
fore, understanding the molecular basis of the kinetic behav-
ior of kv1.4 channel in response to changes in PH and [K
+]0
may be of considerable physiological importance.
Ion channels undergo substantial physical rearrangements
during gating when they transition between conducting and
non-conducting states. This rearrangements can have a strong
influence on channel affinity and drug binding, access to
binding sites, and the environment in which they are in, can
Fig. 6. The dose-responsiveness of propafenone of 1 μ M/L up 1,000 μ M/L on fkv1.4 N channels in 1 mM[K
+]o (squares), 5 mM[K
+] (dia-
monds) and 98 mM[K
+] (triangles) (B). The dose-dependent inhibition of fKv1.4N was in (A). The recordings were graphical with voltage
steps to +50 mv. The graphical evaluation slows the fraction of inhibition of the fkv1.4 N currents. All values represent means±SEM of
the five experiments.
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Fig. 7. Effects of the extracellular PH on the dose-responsiveness
of propafenone on fkv1.4 N channel at  extracellular potassium
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+]0. Xenopus
oocytes with all covering tissues. The PH value of the extracellu-
lar solution was changed by PH 6 (triangles) and PH 7.4 (squares)
and PH 8 (diamonds). Graphical evaluations under propafenone
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uation shows the fraction of inhibition of the fkv1.4 N currents.
All values represents means±SEM of the five experiments each
(I current, U voltage).
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be altered considerably.
The result of study allow to infer on the mechanisms of
action of propafenone at the fkv1.4 N channel molecule.
The voltage dependence of the block suggests that the amount
of block increased with the relative conductance and thus
with the open probability of the fkv1.4 N channel. This
means that the block because more effective when the period
of time was prolonged in which fkv1.4 N channel was in
the open state. The finding allow the conclusion that propa-
fenone blocks the fkv1.4 N channel in the open state. This
is consistent with blocking mechanisms of propafenone found
for kv1.5 (15) and HERG channel (16). The use dependence
of the block shows with the increasing of numbers of open-
ing channels, the block of propafenone on fKv1.4N increased,
that is open channel block.
Previous studies have shown that propafenone binds to the
open conformation of HERG channels, and that propafenone
inhibit the transient outward K current in human atrium,
but this study is the first to examine the relationship between
propafenone binding and C-type inactivation in a voltage-
gated K channel.
Concerning the site of action of propafenone on fkv1.4 N
channel, the results are not decisive. However, there is one
line of evidence might be interpreted to point to a block by
propafenone from the intracellular with lowering of the PH
value. In acidic solution the protonation of propafenone is
increased. Since for an action from the inside, propafenone
has to cross the cell membrane and since it is more likely
that unchanged molecules can transverse into the cell interi-
or, a changing of propafenone by protonation can be assumed
to reduce the concentration of propafenone within the cell,
thus causing smaller blocking effects. For this interpreta-
tion, however, it has to be taken into consideration that the
change of efficacy of propafenone can be assumed to be affect-
ed by the time the channel remained in the open state by
reducing the probability of open channel block. Almost the
same result has been found for the effect of the antiarrhyth-
mic drug quinidine at the Kv1.5 channel and has been taken
as an argument for an action from the inside.
There are two main hypotheses concerning the link bet-
ween occlusion of the intracellular pore by drug or lipophilic
peptides and the coupling to C-type inactivation: the ‘‘per-
meation’’ mechanism and the ‘‘allosteric’’ mechanism. The
permeation mechanism (17) is based on the idea that block-
ing permeation directly effects C-type inactivation. The reduc-
tion in [K
+]0 means fewer K
+ ions bind to the extracellular
binding site, so there is no hindrance to the channel adopt-
ing the C-type inactivated state (17). The allosteric mecha-
nism (18, 19) proposes that the effect of reducing the K
+
accumulation is negligible compared to the contribution
from a direct physical interaction between events at the intra-
cellular pore and C-type inactivation, which are mediated
by the channel protein. C-type inactivation involves a con-
formational change at the extracellular mouth of pore (20).
However, considerable evidence is emerging to indicate that
C-type inactivation also involves major conformational changes
on the intracellular side of the channel. The channel was
regarded as an integrated unit in conformational terms, i.e.
a conformational change at a remote site may result in alloster-
ic changes throughout the protein. This leads to the results
that an action at the intracellular face of the channel can affect
an extracellular event such as C-type inactivation.
Transmembrane communication with allosteric mecha-
nisms connecting physically remote sites has already been
demonstrated for KV1.4 channels, eg. Mutating a valine at
the C-terminal end of S6 has a dramatic effect on C-type inac-
tivation of the KV1.4 channel (21). This kind of transmem-
brane communication is difficult to reconcile with the per-
meation mechanism.
Elevation of [K
+]0 can reduce the affinity for drug binding
by a direct (electrostatic or knock-off) effect or by an indi-
rect effect via modification of the pore region by some kind
of conformational change (allosteric effect), or by a combi-
nation of both (22). If the direct electrostatic effect was the
basis of the interaction, elevating [K
+]0 should reduce propa-
fenone binding to kv1.4 N channel. However, our data
show that increasing [K
+]0 had no significant effect in IC50
of propafenone for fkv1.4 N. This finding cannot be rec-
onciled with the permeation hypothesis. This suggests that
the modulation of drug binding by [K
+] is not the result of
an electrostatic interaction. The allosteric mechanisms dom-
inate coupling in fkv1.4 N channels, and, by extension,
may dominate in the wild type channel.
Recent studies have shown that propafenone blocks the
kv2.1 channel in the open state from the intracellular side
by entering the inner vestibule of the channel. These results
are consistent with a direct interaction of propafenone with
the lower part of the pore helix and/or residues of S6. These
data show there is a link between C-type inactivation medi-
ated pore closure and the propafenone-binding sites in the
intracellular vestibule region. Since the orientation of S6 is
critical to drug binding (23), and recent studies have shown
a link between this domain and C-type inactivation (21), This
suggests that S6 moves during C-type inactivation. There-
fore, the conformational change accompanying C-type inac-
tivation includes more of the channel than previously thought
and has allosteric effect on the intracellular propafenone-bind-
ing site. The molecular sites of action of propafenone on
fkv1.4 N channel is not fully clear. Previous studies have
shown that PH change influence of c-inactivation involves
the change on H508 and K532, and that a model of kv1.4
pore based on the crystal structure of KcsA, shows that H508
and K532 lie close together. Our study concludes that pro-
pafenone acts from the intracellular side of the membrane,
and may result in a structural change near the sites of H508
and K532. Several regions have been found that when replaced
by the corresponding parts of the Kv1.2 channel, reduced
the sensitivity of the PROP for Kv2.1 channel (24). Replace-90 Z. Wang, S. Wang, J. Li, et al.
ment of the intracellular termini and the intracellular linker
S4-S5 induced moderate effects. Because there is growing
evidence that these parts of the channel form an intracellu-
lar compartment placed near membrane-associated part of
the channel pore (25), the intracellular termini and the S4-
S5 linker might impair the access of PROP to its proper site
of action in the internal mouth of the channel. A complete
abolition of PROP sensitivity of Kv2.1 (to the level of Kv1.2)
was found with exchanges of the linker S5-S6, as well as with
the S6 segment itself. Based on radiography analysis of the
KcsA potassium channel, these parts can be assumed to form
the inner wall of the pore proper (26). The intracellular amino
and carboxyl terminus and the intracellular linker S4-S5
reduced the blocking effect of propafenone, whereas the link-
er S5-S6, as well as the segment S6 of the Kv1.2 channel. In
the linker S5-S6, this effect could be narrowed down to two
groups of amino acids (groups 372 to 374 and 383 to 384),
which also affected the sensitivity tetraethylammonium. In
segment S6, several amino acids in the intracellularly direct-
ed part of the helix significantly reduced propafenone sensi-
tivity (24).
Taking all the findings into consideration, we suggest that
PROP enters the cell by allosteric mechanism across the cell
membrane and acts from the intracellular side. PROR blocks
the Kv1.4 N channel in the inner vestibule of the channel
while it is in the open state. The access of PROP to its bind-
ing site can be impaired by intracellular side. Residues of
segment S6 might contribute to this impairment or to the
formation of the binding site, which most probably includes
the lower part of the pore helix.
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